Cargando…
Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile
In November 2019, The World Health Organization (WHO) issued a draft set of Target Product Profiles (TPPs) describing optimal and minimally acceptable targets for vaccines against Rift Valley fever (RVF), a Phlebovirus with a three segmented genome, in both humans and ruminants. The TPPs contained r...
Autores principales: | Monath, Thomas P., Kortekaas, Jeroen, Watts, Douglas M., Christofferson, Rebecca C., Desiree LaBeaud, Angelle, Gowen, Brian, Peters, Clarence J., Smith, Darci R., Swanepoel, Robert, Morrill, John C., Ksiazek, Thomas G., Pittman, Phillip R, Bird, Brian H., Bettinger, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176985/ https://www.ncbi.nlm.nih.gov/pubmed/32337506 http://dx.doi.org/10.1016/j.jvacx.2020.100060 |
Ejemplares similares
-
Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system
por: Ibrahim, Essam H., et al.
Publicado: (2019) -
Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats
por: Stedman, Anna, et al.
Publicado: (2019) -
Rift valley fever (RVF) viral zoonotic disease steadily circulates in the Mauritanian animals and humans: A narrative review
por: Mohapatra, Ranjan K., et al.
Publicado: (2023) -
Enhanced surveillance for Rift Valley Fever in livestock during El Niño rains and threat of RVF outbreak, Kenya, 2015-2016
por: Oyas, Harry, et al.
Publicado: (2018) -
Rift Valley fever (RVF): a re-emerging zoonotic disease, pathogenesis, epidemiology, current status, and future perspective – correspondence
por: Akash, Shopnil, et al.
Publicado: (2023)